The treatment of melioidosis

Pharmaceuticals

Volumn 3, Issue 5, 2010, Pages 1296-1303

  Inglis, Timothy J J ^a,b  

^a PATHWEST LABORATORY MEDICINE   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Adjunct therapy; Antibiotics; Melioidosis; Treatment

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CEPHALOSPORIN; COTRIMOXAZOLE; DOXYCYCLINE; DROTRECOGIN; FOLIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; IMIPENEM; MEROPENEM;

ANTIBIOTIC SENSITIVITY; ARTICLE; BONE AND JOINT INFECTIONS; CENTRAL NERVOUS SYSTEM INFECTION; CLINICAL TRIAL; CONTINUOUS INFUSION; DISEASE SEVERITY; DRUG CHOICE; DRUG EFFICACY; DRUG USE; ERADICATION THERAPY; HUMAN; INFECTION PREVENTION; MAINTENANCE THERAPY; MELIOIDOSIS; NONHUMAN; PRACTICE GUIDELINE; PROSTATITIS; REINFECTION; SEPTICEMIA; TREATMENT DURATION; TREATMENT PLANNING;

EID: 77954948715     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph3051296     Document Type: Article

References (33)

1. Wuthiekanun, V.; Peacock, S.J. Management of melioidosis. Exp. Rev. AntiInfect.Ther. 2006, 4, 445-455.
2. Inglis, T.J.; Rolim, D.B.; Rodriguez, J.L. Clinical guideline for diagnosis and management of melioidosis. Rev. Inst. Med. Trop. São Paulo 2006, 48, 1-4.
3. Cheng, A.C.; Currie, B.J. Melioidosis: epidemiology, pathophysiology, and management. Clin. Microbiol. Rev. 2005; 18, 383-416. Erratum in: Clin. Microbiol. Rev. 2007, 20: 533.
4. Ulett, G.C.; Hirst, R.; Bowden, B.; Powell, K.; Norton, R. A comparison of antibiotic regimens in the treatment of acute melioidosis in a mouse model. J. Antimicrob. Chemother. 2003, 51, 77-81.
5. Simpson, A.J.; Suputtamongkol, Y.; Smith, M.D.; Angus, B.J.; Rajanuwong, A.; Wuthiekanun, V.; Howe, P.A.; Walsh, A.L.; Chaowagul, W.; White, N.J. Comparison of imipenem and ceftazidime as therapy for severe melioidosis. Clin. Infect. Dis. 1999, 29, 381-387.
6. Cheng, A.C.; Fisher, D.A.; Anstey, N.M.; Stephens, D.P.; Jacups, S.P.; Currie, B.J. Outcomes of patients with melioidosis treated with meropenem. Antimicrob. Agents Chemother. 2004, 48, 1763-1765.
7. Inglis, T.J.; Rodrigues, F.; Rigby, P.; Norton, R.; Currie, B.J. Comparison of the susceptibilities of Burkholderia pseudomallei to meropenem and ceftazidime by conventional and intracellular methods. Antimicrob. Agents Chemother. 2004, 48, 2999-3005.
8. Jenney, A.W.; Lum, G.; Fisher, D.A.; Currie, B.J. Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis. Int. J. Antimicrob. Agents 2001, 17, 109-113.
9. Huffam, S.; Jacups, S.P.; Kittler, P.; Currie, B.J. Out of hospital treatment of patients with melioidosis using ceftazidime in 24 h elastomeric infusors, via peripherally inserted central catheters. Trop. Med. Int. Health. 2004, 9, 715-717.
10. Chierakul, W.; Anunnatsiri, S.; Chaowagul, W.; Peacock, S.J.; Chetchotisakd, P.; Day, N.P. Addition of trimethoprim-sulfamethoxazole to ceftazidime during parenteral treatment of melioidosis is not associated with a long-term outcome benefit. Clin. Infect. Dis. 2007, 45, 521-523.
11. Inglis, T.J.; Golledge, C.L.; Clair, A.; Harvey, J. Case report: recovery from persistent septicemic melioidosis. Am. J. Trop. Med. Hyg. 2001, 65, 76-82.
12. Chaowagul, W.; Suputtamongkol, Y.; Dance, D.A.; Rajchanuvong, A.; Pattara-arechachai, J.; White, N.J. Relapse in melioidosis: incidence and risk factors. J. Infect. Dis. 1993, 168, 1181-1185.
13. Chaowagul, W.; Chierakul, W.; Simpson, A.J.; Short, J.M.; Stepniewska, K.; Maharjan, B.; Rajchanuvong, A.; Busarawong, D.; Limmathurotsakul, D.; Cheng, A.C.; Wuthiekanun, V.; Newton, P.N.; White, N.J.; Day, N.P.; Peacock, S.J. Open-label randomized trial of oral trimethoprim-sulfamethoxazole, doxycycline, and chloramphenicol compared with trimethoprimsulfamethoxazole and doxycycline for maintenance therapy of melioidosis. Antimicrob. Agents Chemother. 2005, 49, 4020-4025.
14. Chierakul, W.; Wangboonskul, J.; Singtoroj, T.; Pongtavornpinyo, W.; Short, J.M.; Maharjan, B.; Wuthiekanun, V.; Dance, D.A.; Teparrukkul, P.; Lindegardh, N.; Peacock, S.J.; Day, N.P.; Chaowagul, W.; White, N.J. Pharmacokinetic and pharmacodynamic assessment of co-amoxiclav in the treatment of melioidosis. J. Antimicrob. Chemother. 2006, 58, 1215-1220.
15. Cheng, A.C.; Chierakul, W.; Chaowagul, W.; Chetchotisakd, P.; Limmathurotsakul, D.; Dance, D.A.; Peacock, S.J.; Currie, B.J. Consensus guidelines for dosing of amoxicillin-clavulanate in melioidosis. Am. J. Trop. Med. Hyg.2008, 78, 208-209.
16. Maharjan B, Chantratita N, Vesaratchavest M, Cheng A, Wuthiekanun V, Chierakul W, Chaowagul W, Day NP, Peacock SJ. Recurrent melioidosis in patients in northeast Thailand is frequently due to reinfection rather than relapse. J Clin Microbiol. 2005, 43(12), 6032-6034.
17. How, S.H.; Ng, T.H.; Jamalludin, A.R.; Tee, H.P.; Kuan, Y.C.; Alex, F.; Sc, M.; Aminudin, C.A.; Sapari, S.; Quazi, M.H. Pahang melioidosis registry. Med. J. Malays. 2009, 64, 27-30.
18. Limmathurotsakul, D.; Chaowagul, W.; Chierakul, W.; Stepniewska, K.; Maharjan, B.; Wuthiekanun, V.; White, N.J.; Day, N.P.; Peacock, S.J. Risk factors for recurrent melioidosis in northeast Thailand. Clin. Infect. Dis. 2006, 43, 979-986.
19. Limmathurotsakul, D.; Chaowagul, W.; Chantratita, N.; Wuthiekanun, V.; Biaklang, M.; Tumapa, S.; White, N.J.; Day, N.P.; Peacock, S.J. A simple scoring system to differentiate between relapse and re-infection in patients with recurrent melioidosis. Pub. Lib. Sci. Negl. Trop. Dis. 2008, 2, e327.
20. Stephens, D.P.; Fisher, D.A.; Currie, B.J. An audit of the use of granulocyte colony-stimulating factor in septic shock. Intern. Med. J. 2002, 32, 143-148.
21. Cheng, A.C.; Limmathurotsakul, D.; Chierakul, W.; Getchalarat, N.; Wuthiekanun, V.; Stephens, D.P.; Day, N.P.; White, N.J.; Chaowagul, W.; Currie, B.J.; Peacock, S.J. A randomized controlled trial of granulocyte colony-stimulating factor for the treatment of severe sepsis due to melioidosis in Thailand. Clin. Infect. Dis. 2007, 45, 308-314.
22. Tan, C.K.; Chan, K.S.; Yu, W.L.; Chen, C.M.; Cheng, K.C. Successful treatment of lifethreatening melioidosis with activated protein C and meropenem. J. Microbiol. Immunol. Infect. 2007, 40, 83-87.
23. Donnino, M.W.; Cocchi, M.N.; Howell, M.; Clardy, P.; Talmor, D.; Cataldo, L.; Chase, M.; AlMarshad, A.; Ngo, L.; Shapiro, N.I. Statin therapy is associated with decreased mortality in patients with infection. Acad. Emerg. Med. 2009, 16, 230-234.
24. Kopterides, P.; Falagas, M.E. Statins for sepsis: a critical and updated review. Clin. Microbiol. Infect. 2009, 15, 325-334.
25. Ashdown, L.R. Serial serum C-reactive protein levels as an aid to the management of melioidosis. Am. J. Trop. Med. Hyg. 1992, 46, 151-157.
26. Cheng, A.C.; Obrien, M.; Jacups, S.P.; Anstey, N.M.; Currie, B.J. C-reactive protein in the diagnosis of melioidosis. Am. J. Trop. Med. Hyg. 2004, 70, 580-2.
27. Guilhot, A.; Bricaire, F.; Bossi, P. Glanders, melioidosis and biowarfare. Presse Med. 2005, 34, 185-188.
28. Schlech, W.F., 3rd; Turchik, J.B.; Westlake, R.E. Jr; Klein, G.C.; Band, J.D.; Weaver, R.E. Laboratory-acquired infection with Pseudomonas pseudomallei (melioidosis). New Engl. J. Med. 1981, 305, 1133-1135.
29. Inglis, T.J.; Garrow, S.C.; Henderson, M.; Clair, A.; Sampson, J.; O'Reilly, L.; Cameron, B. Burkholderia pseudomallei traced to water treatment plant in Australia. Emerg. Infect. Dis. 2000, 6, 56-59.
30. Peacock, S.J.; Schweizer, H.P.; Dance, D.A.; Smith, T.L.; Gee, J.E.; Wuthiekanun, V.; DeShazer, D.; Steinmetz, I.; Tan, P.; Currie, B.J. Management of accidental laboratory exposure to Burkholderia pseudomallei and B. mallei. Emerg. Infect. Dis. 2008, 14: e2.
31. Sivalingam, S.P.; Sim, S.H.; Jasper, L.C.; Wang, D.; Liu, Y.; Ooi, E.E. Pre- and post-exposure prophylaxis of experimental Burkholderia pseudomallei infection with doxycycline, amoxicillin/clavulanic acid and co-trimoxazole. J. Antimicrob. Chemother. 2008, 61, 674-678.
32. Thamlikitkul, V.; Trakulsomboon, S. In vitro activity of doripenem against Burkholderia pseudomallei. Antimicrob. Agents Chemother. 2009, 53, 3115-3117.
33. Thamlikitkul, V.; Trakulsomboon, S. In vitro activity of ceftobiprole against Burkholderia pseudomallei. J. Antimicrob. Chemother. 2008, 61, 460-461.